1,2-dimethylhydrazine increases expression ISO RGD:736883 6480464 1, 2-Dimethylhydrazine results in increased expression of ADCY5 mRNA CTD PMID:22206623 17beta-estradiol increases expression ISO RGD:736883 6480464 Estradiol results in increased expression of ADCY5 mRNA CTD PMID:19484750 17beta-estradiol increases expression ISO RGD:736882 6480464 Estradiol results in increased expression of ADCY5 mRNA CTD PMID:31614463 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:736883 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased expression of ADCY5 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ADCY5 promoter] CTD PMID:19654925 , PMID:21212295 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ADCY5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:736883 6480464 Tetrachlorodibenzodioxin results in decreased expression of ADCY5 mRNA CTD PMID:19933214 , PMID:21212295 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:736883 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of ADCY5 mRNA CTD PMID:26251327 4,4'-sulfonyldiphenol increases expression ISO RGD:736883 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ADCY5 mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:736883 6480464 Fenretinide results in decreased expression of ADCY5 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ADCY5 mRNA CTD PMID:24780913 7,12-dimethyltetraphene decreases expression EXP 6480464 9 more ... CTD PMID:12376462 acetamide increases expression EXP 6480464 acetamide results in increased expression of ADCY5 mRNA CTD PMID:31881176 acetylcholine increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Acetylcholine CTD PMID:12869393 acrylamide decreases expression ISO RGD:736882 6480464 Acrylamide results in decreased expression of ADCY5 mRNA CTD PMID:32763439 aflatoxin B1 increases methylation ISO RGD:736882 6480464 Aflatoxin B1 results in increased methylation of ADCY5 exon, Aflatoxin B1 results in increased methylation of ADCY5 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:736882 6480464 aflatoxin B2 results in increased methylation of ADCY5 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:736882 6480464 Tretinoin results in increased expression of ADCY5 mRNA CTD PMID:23830798 aristolochic acid A increases expression ISO RGD:736882 6480464 aristolochic acid I results in increased expression of ADCY5 mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:736883 6480464 arsenite results in increased expression of ADCY5 mRNA CTD PMID:33053406 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of ADCY5 gene CTD PMID:28931070 atropine increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Atropine CTD PMID:12869393 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of ADCY5 mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO RGD:736882 6480464 Benzo(a)pyrene results in decreased expression of ADCY5 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:736882 6480464 Benzo(a)pyrene affects the methylation of ADCY5 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO RGD:736882 6480464 Benzo(a)pyrene results in increased methylation of ADCY5 exon, Benzo(a)pyrene results in increased methylation of ADCY5 promoter CTD PMID:27901495 benzo[b]fluoranthene increases expression ISO RGD:736883 6480464 benzo(b)fluoranthene results in increased expression of ADCY5 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:736882 6480464 benzo(e)pyrene results in increased methylation of ADCY5 intron CTD PMID:30157460 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ADCY5 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:736882 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ADCY5 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:736883 6480464 bisphenol A results in increased expression of ADCY5 mRNA CTD PMID:30951980 , PMID:32370801 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ADCY5 mRNA CTD PMID:30816183 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ADCY5 mRNA CTD PMID:29097150 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ADCY5 gene CTD PMID:28505145 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of ADCY5 gene CTD PMID:28505145 bisphenol F decreases expression EXP 6480464 4, 4'-bisphenol F results in decreased expression of ADCY5 mRNA CTD PMID:26186136 bisphenol F increases expression ISO RGD:736883 6480464 bisphenol F results in increased expression of ADCY5 mRNA CTD PMID:30951980 cadmium dichloride decreases expression ISO RGD:736882 6480464 Cadmium Chloride results in decreased expression of ADCY5 mRNA CTD PMID:21457566 caffeine decreases expression EXP 6480464 Caffeine results in decreased expression of ADCY5 mRNA CTD PMID:26367767 calcium atom decreases activity ISO RGD:736882 6480464 Calcium results in decreased activity of ADCY5 protein CTD PMID:12065575 calcium atom increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Calcium CTD PMID:12869393 calcium(0) decreases activity ISO RGD:736882 6480464 Calcium results in decreased activity of ADCY5 protein CTD PMID:12065575 calcium(0) increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Calcium CTD PMID:12869393 cannabidiol increases expression ISO RGD:736883 6480464 Cannabidiol results in increased expression of ADCY5 mRNA CTD PMID:33019509 cannabigerol increases expression ISO RGD:736883 6480464 cannabigerol results in increased expression of ADCY5 mRNA CTD PMID:33019509 carbachol increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Carbachol CTD PMID:12869393 carbon nanotube decreases expression ISO RGD:736883 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGS-21680 multiple interactions ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine co-treated with Quinpirole] CTD PMID:12223546 CGS-21680 increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine CTD PMID:12223546 chlordecone increases expression ISO RGD:736883 6480464 Chlordecone results in increased expression of ADCY5 mRNA CTD PMID:33711761 clozapine affects response to substance ISO RGD:736883 6480464 ADCY5 protein affects the susceptibility to Clozapine CTD PMID:12223546 clozapine multiple interactions ISO RGD:736883 6480464 SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Clozapine] CTD PMID:12223546 colforsin daropate hydrochloride multiple interactions ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to [Colforsin co-treated with Quinpirole] CTD PMID:12223546 crocidolite asbestos increases expression ISO RGD:736883 6480464 Asbestos, Crocidolite results in increased expression of ADCY5 mRNA CTD PMID:23917077 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of ADCY5 mRNA CTD PMID:23640034 dibutyl phthalate increases expression ISO RGD:736883 6480464 Dibutyl Phthalate results in increased expression of ADCY5 mRNA CTD PMID:21266533 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of ADCY5 mRNA CTD PMID:18636392 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of ADCY5 mRNA CTD PMID:29391264 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ADCY5 mRNA CTD PMID:20655511 ethanol increases expression ISO RGD:736883 6480464 Ethanol results in increased expression of ADCY5 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:736883 6480464 Ethanol affects the expression of and affects the splicing of ADCY5 mRNA CTD PMID:30319688 folic acid decreases expression ISO RGD:736883 6480464 Folic Acid results in decreased expression of ADCY5 mRNA CTD PMID:25629700 formaldehyde decreases expression EXP 6480464 Formaldehyde results in decreased expression of ADCY5 mRNA CTD PMID:14756816 fulvestrant multiple interactions ISO RGD:736882 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ADCY5 gene CTD PMID:31601247 genistein multiple interactions EXP 6480464 [bisphenol A co-treated with Genistein] results in increased methylation of ADCY5 gene CTD PMID:28505145 genistein increases expression ISO RGD:736883 6480464 Genistein results in increased expression of ADCY5 mRNA CTD PMID:32186404 haloperidol affects response to substance ISO RGD:736883 6480464 ADCY5 protein affects the susceptibility to Haloperidol CTD PMID:12223546 haloperidol multiple interactions ISO RGD:736883 6480464 SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Haloperidol] CTD PMID:12223546 isoprenaline multiple interactions ISO RGD:736883 6480464 [ADCY5 protein results in increased susceptibility to Isoproterenol] which results in decreased expression of SOD2 protein, SOD2 protein inhibits the reaction [ADCY5 protein results in increased susceptibility to Isoproterenol] CTD PMID:23536361 isoprenaline increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Isoproterenol CTD PMID:12869393 , PMID:23536361 lipopolysaccharide multiple interactions ISO RGD:736883 6480464 [Tetrachlorodibenzodioxin co-treated with Lipopolysaccharides] results in decreased expression of ADCY5 mRNA CTD PMID:21212295 lipopolysaccharide increases expression ISO RGD:736883 6480464 Lipopolysaccharides results in increased expression of ADCY5 mRNA CTD PMID:21212295 magnesium atom increases activity ISO RGD:736882 6480464 Magnesium results in increased activity of ADCY5 protein CTD PMID:12065575 methapyrilene increases methylation ISO RGD:736882 6480464 Methapyrilene results in increased methylation of ADCY5 intron CTD PMID:30157460 monosodium L-glutamate increases expression EXP 6480464 Sodium Glutamate results in increased expression of ADCY5 mRNA CTD PMID:20928830 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of ADCY5 mRNA CTD PMID:26720608 O-methyleugenol decreases expression ISO RGD:736882 6480464 methyleugenol results in decreased expression of ADCY5 mRNA CTD PMID:32234424 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of ADCY5 mRNA CTD PMID:18636392 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ADCY5 mRNA CTD PMID:17077588 phenylephrine increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Phenylephrine CTD PMID:12869393 PhIP decreases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in decreased expression of ADCY5 mRNA CTD PMID:12376462 pioglitazone multiple interactions ISO RGD:736883 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of ADCY5 mRNA CTD PMID:27935865 progesterone increases expression EXP 6480464 Progesterone results in increased expression of ADCY5 mRNA CTD PMID:20726854 quinpirole multiple interactions ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine co-treated with Quinpirole] more ... CTD PMID:12223546 SCH 23390 multiple interactions ISO RGD:736883 6480464 SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Clozapine], SCH 23390 inhibits the reaction [ADCY5 protein affects the susceptibility to Haloperidol] CTD PMID:12223546 silicon dioxide decreases expression ISO RGD:736882 6480464 Silicon Dioxide analog results in decreased expression of ADCY5 mRNA CTD PMID:25895662 SKF 38393 increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to 2 more ... CTD PMID:12223546 sodium arsenite decreases expression ISO RGD:736882 6480464 sodium arsenite results in decreased expression of ADCY5 mRNA CTD PMID:29301061 , PMID:32844245 sodium arsenite increases methylation ISO RGD:736882 6480464 sodium arsenite results in increased methylation of ADCY5 intron CTD PMID:32844245 sulpiride increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Sulpiride CTD PMID:12223546 sunitinib decreases expression ISO RGD:736882 6480464 Sunitinib results in decreased expression of ADCY5 mRNA CTD PMID:31533062 triclosan increases expression EXP 6480464 Triclosan results in increased expression of ADCY5 mRNA CTD PMID:30447264 tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate increases response to substance ISO RGD:736883 6480464 ADCY5 protein results in increased susceptibility to Atropine CTD PMID:12869393 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of ADCY5 mRNA CTD PMID:23665938 valproic acid increases methylation ISO RGD:736882 6480464 Valproic Acid results in increased methylation of ADCY5 gene CTD PMID:29154799 XL147 multiple interactions ISO RGD:736883 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of ADCY5 mRNA CTD PMID:27935865
